Technical Analysis for INSM - Insmed, Inc.

Grade Last Price % Change Price Change
D 70.30 -0.92% -0.66
INSM closed down 0.92 percent on Wednesday, October 30, 2024, on 74 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down

Date Alert Name Type % Chg
Cup with Handle Other 0.00%
Stochastic Reached Oversold Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Doji - Bullish? Reversal -0.92%
Gapped Down Weakness -0.92%
Pocket Pivot Bullish Swing Setup -2.31%
NR7 Range Contraction -2.31%
Inside Day Range Contraction -2.31%
Gapped Up Strength -2.31%
Earnings Movers Other -0.94%

   Recent Intraday Alerts

Alert Time
Fell Below Previous Day's Low about 13 hours ago
Down 1% about 13 hours ago
60 Minute Opening Range Breakdown about 13 hours ago
Possible NR7 about 14 hours ago
Possible Inside Day about 14 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Insmed, Inc. Description

Insmed Incorporated, a biopharmaceutical company, focuses on developing and commercializing targeted inhalation therapies for patients battling serious lung diseases. Its lead candidate ARIKACE is engineered to deliver a proven and potent anti-infective directly to the site of serious lung infections to improve the treatment for two identified patient populations comprising cystic fibrosis (CF) patients with Pseudomonas aeuruginosa lung infections and patients with nontuberculous mycobacteria lung infections (NTM). The company's Phase III registrational study of ARIKACE in CF patients in Europe and Canada has completed enrollment; and Phase II clinical trial in NTM patients is under way with clinical results. Insmed Incorporated was founded in 1999 and is headquartered in Monmouth Junction, New Jersey.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Infectious Diseases Cystic Fibrosis Microbiology Bacterial Disease Pseudomonas Tuberculosis Bacteriology Lung Diseases Lung Infection Nontuberculous Mycobacteria Lung Infections Mycobacterium

Is INSM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 80.53
52 Week Low 21.92
Average Volume 1,571,695
200-Day Moving Average 50.90
50-Day Moving Average 73.49
20-Day Moving Average 72.54
10-Day Moving Average 72.26
Average True Range 2.06
RSI (14) 42.20
ADX 12.59
+DI 13.31
-DI 20.56
Chandelier Exit (Long, 3 ATRs) 71.53
Chandelier Exit (Short, 3 ATRs) 75.25
Upper Bollinger Bands 76.17
Lower Bollinger Band 68.90
Percent B (%b) 0.19
BandWidth 10.02
MACD Line -0.54
MACD Signal Line -0.22
MACD Histogram -0.3141
Fundamentals Value
Market Cap 10.06 Billion
Num Shares 143 Million
EPS -5.29
Price-to-Earnings (P/E) Ratio -13.29
Price-to-Sales 14.32
Price-to-Book 25.45
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 72.35
Resistance 3 (R3) 72.48 71.93 72.01
Resistance 2 (R2) 71.93 71.40 71.86 71.89
Resistance 1 (R1) 71.11 71.08 70.83 70.98 71.78
Pivot Point 70.56 70.56 70.42 70.49 70.56
Support 1 (S1) 69.74 70.03 69.46 69.61 68.81
Support 2 (S2) 69.19 69.71 69.12 68.70
Support 3 (S3) 68.37 69.19 68.58
Support 4 (S4) 68.24